Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is 3613,68 zł, with a 24-hour trading volume of 6,97B zł. The asset's market cap is 3,4T zł, after moving -1.34% in the last day.
Tokenized Eli Lilly And Co is trading at 3622,05 zł, with a tokenized market cap of 19,7M zł and a 24-hour trading volume of 6,24M zł. The tokenized asset has moved 0.33% in the past 24 hours.